Magne Aarsnes is allocated 309 shares in Hofseth BioCare ASA.
The allotment is related to the fulfillment of the "non-sale"-clause in the in the retail tranche in the company's IPO in December 2011, where Magne Aarsnes was allocated 2,799 shares.
Following the transaction, Magne Aarsnes holds 3,088 shares in Hofseth BioCare ASA.
Magne Aarsnes is CFO and primary insider in Hofseth BioCare ASA.
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.